XTX Topco’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-27,133
| Closed | -$674K | – | 2966 |
|
|
2025
Q1 | $674K | Sell |
27,133
-605
| -2% | -$15K | 0.03% | 807 |
|
|
2024
Q4 | $523K | Buy |
+27,738
| New | +$523K | 0.04% | 728 |
|
|
2024
Q3 | – | Sell |
-9,222
| Closed | -$264K | – | 2464 |
|
|
2024
Q2 | $264K | Buy |
9,222
+88
| +1% | +$2.52K | 0.02% | 1047 |
|
|
2024
Q1 | $267K | Buy |
+9,134
| New | +$267K | 0.04% | 950 |
|
|
2023
Q4 | – | Sell |
-13,588
| Closed | -$417K | – | 1983 |
|
|
2023
Q3 | $417K | Buy |
13,588
+5,557
| +69% | +$170K | 0.07% | 505 |
|
|
2023
Q2 | $322K | Buy |
+8,031
| New | +$322K | 0.06% | 669 |
|
|
2023
Q1 | – | Sell |
-17,522
| Closed | -$677K | – | 1564 |
|
|
2022
Q4 | $677K | Buy |
+17,522
| New | +$677K | 0.14% | 187 |
|
|
2021
Q2 | – | Sell |
-2,886
| Closed | -$202K | – | 1025 |
|
|
2021
Q1 | $202K | Buy |
+2,886
| New | +$202K | 0.1% | 497 |
|